Topical GHK-Cu serums contain the peptide at concentrations that vary widely by brand
Regulatory note: Injectable/IV NAD+ is not FDA-approved (or approved by any major regulator) for energy, metabolic or longevity uses
(2019) Predictive Factors of Efficacy Maintenance after Testosterone Treatment Cessation Kim SH, Park MJ
Active rash, severe irritation or persistent acne requires suitable professional care rather than increasingly complex product stacking
Instead of focusing primarily on blood flow, PT-141 acts on receptors in the brain associated with desire, arousal, and sexual response
Reported Research Benefits Used in preclinical research focused on obesity, metabolic syndrome, diabetes, aging-related metabolic decline, fat mass reduction, and muscle preservation during caloric deficit